Low and High Radio-Iodine-131 Doses in Postoperative Ablation in Differentiated Thyroid Carcinoma

Impact of Ablative Low Dose Radio-Active Iodine after Thyroidectomy in Low–Risk Differentiated Thyroid Cancer

Ablation outcomes of low versus high doses of radioiodine ( I) in patients with differentiated thyroid carcinoma following thyroidectomy

Effect of Different Ablative Doses of Radioactive Iodine in Patients with Differentiated Thyroid Carcinoma and Cervical Lymph Node Metastasis

Thyroid Remnant Ablation of Differentiated Thyroid Carcinoma: a comparison of Ablation success with High and Low Doses of Radio-iodine

The Impact of Thyroid Stunning on Radioactive Iodine Ablation Compared to Other Risk Factors

Factors affecting ablation outcome in low and intermediate risk patients with differentiated thyroid cancer.

ASSESSMENT OF TREATMENT RESPONSE TO 131I THERAPY FOR PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA IN THE PAST THREE YEARS (Single Institutional Experience)

Successful Complete Ablation Rate Post a Second Ablation Dose of 30 mCi Radioactive Iodine (I131) in Patients with Papillary Thyroid Cancer

Impact of Post-Thyroidectomy I-123 Versus I-131 Whole Body Scan on the Outcome of Radioactive Iodine (I-131) Ablation for Differentiated Thyroid Carcinoma